4,5-diamino-10-(4-nitrophenyl)-9,10-dihydro-1H,8H-1,3,6,8,9-pentaazaantrecen-2,7-dithione

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡啶并嘧啶类
• 英文名称: 4,5-diamino-10-(4-nitrophenyl)-9,10-dihydro-1H,8H-1,3,6,8,9-pentaazaantrecen-2,7-dithione
• 英文别名: 4,6-Diamino-5-(4-nitrophenyl)-1,5,9,10-tetrahydropyrimidino[5',4'-6,5]pyridino[2,3-d]pyrimidine-2,8-dithione；7,11-diamino-9-(4-nitrophenyl)-2,4,6,12,14-pentazatricyclo[8.4.0.03,8]tetradeca-1(14),3,7,10-tetraene-5,13-dithione
• 化学式: C₁₅H₁₂N₈O₂S₂
• 分子量: 400.445
• InChiKey: WAMNBOGLJDQORP-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0
• 重原子数：
  27
• 可旋转键数：
  1
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.07
• 拓扑面积：
  223
• 氢给体数：
  5
• 氢受体数：
  6

反应信息

• 作为产物：
  描述：

  4,6-dichlorine-5-(4-nitrophenyl)-5,9-dihydro-1H-pyrano[2,3-d;6,5-d']dipyrimidine-2,8-dithione 在 氨 、 水 作用下， 反应 24.0h， 以31%的产率得到4,5-diamino-10-(4-nitrophenyl)-9,10-dihydro-1H,8H-1,3,6,8,9-pentaazaantrecen-2,7-dithione
  参考文献：
  名称：

  EP1669357

  摘要：

  公开号：

文献信息

• Substance which exhibits antiviral and antibacterial activity and is based on derivatives of 2,8-dithioxo-1h-pyrano[2,3d 6,5-d']dipyrimidyne and 10-aza-analogue thereof
  申请人：Tets Veniaminovich Viktor

  公开号：US20070037838A1

  公开（公告）日：2007-02-15

  The invention relates to organic chemistry and medicine, more specifically to synthetic pyrimidine derivatives, i.e. 2,8-dithioxo-1H-pyrano[2,3d,6,5-d′]dipyrimidyne and 10-aza-analogue thereof and to the complexes and salts thereof which exhibit antiviral and antimicrobial activity. Said invention can be used for medicine and veterinary science for treating viral diseases, bacteria-induced diseases and for cosmetology in the form of an additive for preventing and treating infections. The aim of said invention is to develop a novel more efficient substance exhibiting antiviral and antimicrobial activity. The inventive substance which exhibits antiviral and antimicrobial activity is based on derivatives of 2,8-dithioxo-1H-pyrano[2,3d,6,5-d′]dipyrimidyne and 10-aza-analogue thereof and characterised in that it comprises the derivative of said group of general formula A1, M, wherein X is selected from a group O, NH, N-Alkyl; R1 is selected from a group H, Oh, Cl, O-Alkyl, NH 2 , NH-Alkyl, NH—Ar, N(Alkyl) 2 , SH, S-Alkyl, S—Ar, S-Hetaryl; R 2 is selected from a group C 6 H 5 , Aryl, R3 is selected from a group H, Cl, O-Alkyl, NH 2 , NH-Alkyl, NH—Ar, S-Heratyl, M is absent or selected from a group of Na, K, Li, ammonium cation or another pharmacologically acceptable cation; or said complex of pharmacologically acceptable cation with the anion of one of derivatives Al (above-mentioned variants R 1 —R 3 ).
• US7557116B2
  申请人：——

  公开号：US7557116B2

  公开（公告）日：2009-07-07
• EP1669357
  申请人：——

  公开号：——

  公开（公告）日：——